期刊文献+

去氢雌马酚对急性早幼粒白血病NB4细胞的增殖抑制作用及其初步机制研究 被引量:1

Study on the Anti-proliferation Effect and Preliminary Mechanism of Dehydroequol on NB4 Cells
下载PDF
导出
摘要 目的研究黄酮类化合物去氢雌马酚(dehydroequol)对急性早幼粒白血病NB4细胞的增殖抑制作用,并对其作用机制进行初步研究。方法应用噻唑蓝比色法及台盼蓝计数法观察去氢雌马酚及其结构类似物对不同肿瘤细胞增殖的影响,并应用细胞周期分析及细胞凋亡检测研究去氢雌马酚抑制NB4细胞增殖的机制。结果通过比较去氢雌马酚及其3个结构类似化合物对NB4细胞的增殖抑制作用。发现去氢雌马酚抗肿瘤活性最强,并且去氢雌马酚能显著抑制多种肿瘤细胞增殖,其中对急性早幼粒细胞白血病NB4细胞的抑制作用更显著,并能浓度与时间依赖性地抑制NB4细胞增殖,引起NB4细胞G1期阻滞并诱导细胞凋亡。结论去氢雌马酚对急性早幼粒白血病NB4细胞的增殖有很强的抑制作用,并且通过引起细胞G1期阻滞和诱导细胞凋亡而显著抑制NB4细胞的增殖。 Objective To study the anti-proliferation effect and preliminary mechanism of dehydroequol on NB4 cells. Methods Thiazole blue colorimetry and typan blue exclusion assay were used to study the effect of de- hydroequol and analogues on proliferation of several types of tumor cells. Cell cycle analysis and apoptosis assay were used to investigate the preliminary mechanism of dehydroequol on NB4 cells. Results Dehydroequol was the strongest of these compounds by comparmy dehydroequol and its analogs. Dehydroequol significantly inhibited the proliferation of many cancer cell lines, especially the proliferation of NB4 cells. Dehydroequol significantly inhibited the proliferation of NB4 cells in a close and time dependent manner, arrested NB4 cells in G1 phase and induced apoptosis in NB4 ceils. Conclusion Dehydroequol can exert a conspicuous anti-proliferation on NB4 cells possibly by arresting NB4 cells in G1 phase and inducing apoptosis in NB4 cells.
出处 《解放军药学学报》 CAS 2013年第3期192-195,共4页 Pharmaceutical Journal of Chinese People's Liberation Army
基金 国家自然科学基金资助项目 No.81273544
关键词 去氢雌马酚 急性早幼粒白血病NB4细胞 细胞增殖抑制 dehydroequol acute promyelocytic leukemia NB4 inhibition of cell proliferation
  • 相关文献

参考文献10

  • 1Wang ZY, Chen Z. Acute promyelocytic leukemia: from highly fa- tal to highly curable [ J ]. Blood,2008,111 ( 5 ) : 2505 - 2515.
  • 2Kamsteeg M, Rutherford T, Sapi E, et al. Phenoxodiol-an isofla- vone analog-induces apoptosis in chemoresistant ovarian cancer cells [ J ]. Oncogene ,2003,22 ( 17 ) :2611 - 2620.
  • 3Constantinou AI, Mehta R, Husband A. Phenoxodiol, a novel isofla- vone derivative, inhibits dimethylbenz [ a anthracene (DMBA) -in- duced mammary carcinogenesis in female Sprague-Dawley rats [ J 1. Eur J of Cancer,2003,39(7) ;1012 - 1018.
  • 4Mahoney S, Arfuso F, Rogers p, et al. Cytotoxic effects of the no- vel isoflavone, phenoxodiol, on prostate cancer cell lines [ J ]. J Bio- sci ,2012,37 ( 1 ) :73 - 84.
  • 5Saif MW,Tytler E,Lansigan F, et al. Flavonoids, phenoxodiol,and a novel agent,triphendiol ,for the treatment of pancreaticobiliary cancers [J]. Expert Opin Investig Drugs,2009,18(4):469 -479.
  • 6Yu F,Watts RN,Zhang XD, et al. Involvement of BH3-only pro- apoptotic proteins in mitochondrial-dependent Phenoxodiol-induced apoptosis of human melanoma cells [ J ]. Anticancer Drugs, 2006, 17(10) :1151 -1161.
  • 7Choueiri TK, Wesolowski R, Mekhail TM. Phenoxodiol: isoflavone analog with antineoplastic activity [ J ]. Curr Oncol Rep, 2006,8 (2):104-107.
  • 8Mcguire WP, Blessing JA, Bookman MA, et al. Topotecan has substantial antltumor activity as first-line salvage therapy in plati- num-sensitive epithelial ovarian carcinoma: A gynecologic oncolo- gy group study [ J ]. J Clin Oncol, 2000,18 ( 5 ) : 1062 - 1067.
  • 9Seiter K. Toxicity of the topoisomera I seinhibitors [ J ]. Expert Opin Drug Saf,2005, 4( 1 ) :45 -53.
  • 10Herst PM,Davis JE,Neeson P, et al. The anti-cancer drug, phenox- odiol, kills primary myeloid and lymphoid leukemic blasts and rapid- ly proliferating T cells[J]. Haematologica,20 ,94(7) :928 -934.

同被引文献22

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部